BD Diagnostics Receives Go-ahead for RSV Test

The BD Veridor System, intended for rapid detection of respiratory syncytial virus, has received FDA approval for clinical use.

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for nasopharyngeal wash, aspirate and swab in transport media specimens on the BD Veritor System for Rapid Detection of respiratory syncytial virus (RSV). This new product is cleared for use in clinical settings.

No votes yet
Syndicate content